Fogliata, A, Bolsi, A, Cozzi, L, Bernier, J. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol 2003; 69 (3): 267–275.
Caraman, A, Buzea, C G, Ojica, S, Oprea, M, Zara, A D, Iancu, D T. A comparison between 3D-CRT, intensity modulated radiotherapy, and volumetric modulated arc therapy techniques for head and neck cancer. J Adv Res Phys 2016; 6 (1): 011601.
Grundmann, O, Mitchell, G C, Limesand, K H. Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res 2009; 88 (10): 894–903.
Rubin, P, Casarett, G. A direction for clinical radiation pathology. In Radiation Effects and Tolerance, Normal Tissue. Front Radiat Ther Oncol 1972; 6: 1–16.
Emami, B, Lyman, J, Brown, A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21 (1): 109–122.
Jones, D. ICRU report 50—prescribing, recording and reporting photon beam therapy. Med Phys 1994; 21 (6): 833–834.
7.Prescribing, I.C.R.U. recording and reporting photon beam therapy (supplement to ICRU report 50). ICRU Report No. 62, 1999. Bethesda, MD.
Gomez-Millan, J, Fernández, J R, Carmona, J A. Current status of IMRT in head and neck cancer. Rep Pract Oncol Radiother 2013; 18 (6): 371–375.
Pathak, P, Vashisht, S. A quantitative analysis of intensity-modulated radiation therapy plans and comparison of homogeneity indices for the treatment of gynecological cancers. J Med Phys 2013; 38 (2): 67–73.
Cozzi, L, Fogliata, A, Lomax, A, Bolsi, A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001; 61 (3): 287–297.
Ang, K K, Zhang, Q, Rosenthal, D I et al. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol 2014; 32 (27): 2940–2950.
Tsudou, S, Takegawa, H, Ueda, Y et al. Accumulated dose of intensity-modulated radiotherapy for head and neck cancer using deformable registration of two sets of computed tomography images. J Nucl Med Radiat Ther 2015; 6: 264–270.
Lønbro, S, Dalgas, U, Primdahl, H, Overgaard, J, Overgaard, K. Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients–the DAHANCA 25A study. Acta Oncol 2013; 52 (2): 310–318.
Bjørndal, K, Krogdahl, A, Therkildsen, M H et al. Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2011; 47: 677–682.
Daoud, M, Saleh, Y, Habash, A. Simultaneous integrated boost by RapidArc therapy plus temozolomide for treatment of patients with glioblastoma multiform: a single institution experience. Int J Cancer Ther Oncol 2015; 3 (3): 3314.
El-Ghoneimy, E G, Hassan, M A, El-Bestar, M F, Othman, O M, Mashhour, K N. A dosimetric comparative study between conformal and intensity modulated radiation therapy in the treatment of primary nasopharyngeal carcinomas: the Egyptian experience. Chinese-German J Clin Oncol 2012; 11 (11): 626–631.
Xia, P, Lee, N, Liu, Y M et al. A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system. Int J Radiat Oncol Biol Phys 2004; 59 (3): 886–896.
Scorsetti, M, Fogliata, A, Castiglioni, S et al. Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients. Radiat Oncol 2010; 5 (1): 93.
Shaw, E, Kline, R, Gillin, M et al. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 1993; 27 (5): 1231–1239.
Knöös, T, Kristensen, I, Nilsson, P. Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index. Int J Radiat Oncol Biol Phys 1998; 42 (5): 1169–1176.
Krishna, G S, Srinivas, V, Ayyangar, K M, Reddy, P Y. Comparative study of old and new versions of treatment planning system using dose volume histogram indices of clinical plans. J Med Phys 2016; 41 (3): 192–197.
Murphy, M J, Chang, S, Gibbs, I, Le, Q T, Martin, D, Kim, D. Image-guided radiosurgery in the treatment of spinal metastases. Neurosurg Focus. 2001; 11 (6): 1–7.
Das, I J, Cheng, C W, Chopra, K L, Mitra, R K, Srivastava, S P, Glatstein, E. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst 2008; 100 (5): 300–307.
Kataria, T, Sharma, K, Subramani, V, Karrthick, K P, Bisht, S S. Homogeneity index: an objective tool for assessment of conformal radiation treatments. J Med Phys 2012; 37 (4): 207–213.
Lu, J Y, Cheung, M L, Li, M, Huang, B T, Xie, W J, Xie, L X. Dosimetric evaluation of a simple planning technique for improving intensity-modulated radiotherapy for nasopharyngeal cancer. PloS One. 2015; 10 (7): e0129461.
Wu, Q, Manning, M, Schmidt-Ullrich, R, Mohan, R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000; 46 (1): 195–205.
Ling, C C, Burman, C, Chui, C S et al. Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys 1996; 35 (4): 721–730.
Sakthi, N, Keall, P, Mihaylov, I et al. Monte Carlo-based dosimetry of head-and-neck patients treated with SIB-IMRT. Int J Radiat Oncol Biol Phys 2006; 64 (3): 968–977.
Yang, W, Zeng, B, Qiu, Y et al A dosimetric comparison of dose escalation with simultaneous integrated boost for locally advanced non-small-cell lung cancer. BioMed Res Int2017; 2017: 9736362, 7 pp.
Cox, J D, Stetz, J, Pajak, T F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31 (5): 1341–1346.
Kim, J W, Cho, J H, Keum, K C et al. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome. Jpn J Clin Oncol 2012; 42 (12): 1152–1160.
Boden, G. Radiation myelitis of the brain-stem. J Fac Radiol 1950; 2 (1): 79–94.
Deasy, J O, Moiseenko, V, Marks, L, Chao, K C, Nam, J, Eisbruch, A. Radiotherapy dose–volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010; 76 (3): S58–S63.
de Arruda, F F, Puri, D R, Zhung, J et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006; 64 (2): 363–373.
Chao, K C, Deasy, J O, Markman, J et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001; 49 (4): 907–916.
Eisbruch, A, Ten Haken, R K, Kim, H M, Marsh, L H, Ship, J A. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45 (3): 577–587.
Eisbruch, A, Kim, H M, Terrell, J E, Marsh, L H, Dawson, L A, Ship, J A. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001; 50 (3): 695–704.
Eisbruch, A, Ship, J A, Dawson, L A et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 2003; 27 (7): 832–837.
Milano, M T, Constine, L S, Okunieff, P. Normal tissue tolerance dose metrics for radiation therapy of major organs. Semin Radiat Oncol 2007; 17 (2): 131–140.
Mira, J G, Wescott, W B, Starcke, E N, Shannon, I L. Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys 1981; 7 (4): 535–541.
Lee, N, Harris, J, Garden, A S et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225. J Clin Oncol 2009; 27 (22): 3684–3690.
Kristensen, I, Nilsson, K, Nilsson, P. Comparative proton and photon treatment planning in pediatric patients with various diagnoses. Int J Part Ther 2015; 2 (2): 367–375.
Lu, J Y, Zhang, J Y, Li, M et al. A simple optimization approach for improving target dose homogeneity in intensity-modulated radiotherapy for sinonasal cancer. Sci Rep 2015; 5: 15361–15369.
Süss, P, Bortz, M, Küfer, K H, Thieke, C. The critical spot eraser—a method to interactively control the correction of local hot and cold spots in IMRT planning. Phys Med Biol 2013; 58 (6): 1855–1867.
Peszynska-Piorun, M, Malicki, J, Golusinski, W. Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT. Radiol Oncol 2012; 46 (4): 328–336.
Hunt, M A, Zelefsky, M J, Wolden, S et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001; 49 (3): 623–632.
Mohan, R, Wu, Q, Manning, M, Schmidt-Ullrich, R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46 (3): 619–630.
Khayaiwong, P, Tungboonduangjit, P, Suriyapee, S et al. Dosimetric comparison between simultaneous integrated boost and sequential intensity-modulated radiotherapy techniques in nasopharyngeal carcinoma. Challenges of Quality Assurance in Radiation Medicine, 6th Annual Scientific Meeting, Phitsanulok, Thailand, 77, 2012.
Moorthy, S, Elhateer, H, Das Majumdar, S K, Shubber, Z, Murthy, N. Hypofractionated IMRT breast treatment with simultaneous versus sequential boost techniques. J Nucl Med Radiat Ther 2012; 3: 130–134.
Chen, S W, Yang, S N, Liang, J A, Shiau, A C, Lin, F J. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer. Med Dosim 2006; 30 (4): 219–227.
Shamsi, Q U, Atiq, M, Atiq, A, Buzdar, S A, Iqbal, K. Analysis of dosimetric indices for evaluating intensity modulated radiotherapy plans of head and neck cancer patients. J Radiol Radiat Ther 2017; 5 (1): 1065–1070.